Related Experiment Videos
[In vitro antibacterial activity of eight third generation cephalosporins (author's transl)]
Abstract:
This work report a study of antibacterial activity of eight third generation cephalosporins : cefotaxime, moxalactam, cefoperazone, cefotiam, ceftazidime, ceftriaxone, cefmenoxime and cefotetan. The essential interest of these antibiotics is their activity against Enterobacteriaceae resistant to cefalothin ; however, five of them are clearly superior ; cefotaxime, moxalactam, cefmenoxime, ceftriaxone and ceftazidime. Ceftazidime is the best against Pseudomonas aeruginosa and moxalactam against the Bacteroides group. Against others bacterial groups, these new cephalosporins are not superior to former products.
Insights
This study evaluated eight third-generation cephalosporins, finding cefotaxime, moxalactam, cefmenoxime, ceftriaxone, and ceftazidime most effective against resistant Enterobacteriaceae. Ceftazidime excelled against Pseudomonas aeruginosa, and moxalactam against Bacteroides.
Area of Science:
- Pharmacology
- Microbiology
- Infectious Diseases
Background:
- Third-generation cephalosporins represent a critical class of antibiotics.
- Emergence of antibiotic resistance necessitates evaluation of newer agents.
- Enterobacteriaceae and Pseudomonas aeruginosa are significant pathogens.
Purpose of the Study:
- To assess the in vitro antibacterial activity of eight third-generation cephalosporins.
- To identify superior agents against cefalothin-resistant Enterobacteriaceae.
- To compare efficacy against specific challenging pathogens like Pseudomonas aeruginosa and Bacteroides.
Main Methods:
- In vitro susceptibility testing of eight third-generation cephalosporins.
- Evaluation of antibacterial spectrum and potency.
- Comparative analysis of efficacy against various bacterial groups, including Enterobacteriaceae, Pseudomonas aeruginosa, and Bacteroides.
Main Results:
- Five cephalosporins (cefotaxime, moxalactam, cefmenoxime, ceftriaxone, ceftazidime) demonstrated superior activity against cefalothin-resistant Enterobacteriaceae.
- Ceftazidime exhibited the strongest activity against Pseudomonas aeruginosa.
- Moxalactam was most effective against the Bacteroides group.
- No significant superiority over older agents was observed against other bacterial groups.
Conclusions:
- Certain third-generation cephalosporins offer significant advantages against resistant Enterobacteriaceae.
- Ceftazidime and moxalactam show specific strengths against key pathogens.
- These findings guide the selection of appropriate cephalosporins for treating infections caused by resistant bacteria.